People at 'Intermediate Risk' of Heart Disease With Elevated hsCRP Benefit from Statin Therapy Even if Cholesterol Levels Are Normal
August 24, 2010
August 24, 2010
DALLAS, Aug. 24 -- The American Heart Association issued the following news release:
Women and men with a 10-year cardiovascular disease risk of 5 percent or more and normal cholesterol levels but high levels of hsCRP, a protein associated with inflammation, could reduce their risk substantially with statin therapy, according to new research.
The study, published in Circulation: Cardiovascular Quality and Outcomes, an American Heart Association journal, is a new ana . . .
Women and men with a 10-year cardiovascular disease risk of 5 percent or more and normal cholesterol levels but high levels of hsCRP, a protein associated with inflammation, could reduce their risk substantially with statin therapy, according to new research.
The study, published in Circulation: Cardiovascular Quality and Outcomes, an American Heart Association journal, is a new ana . . .